| Nanoliposomes for doxorubicin delivery: Reversing drug resistance, stimuli-responsive carriers and clinical translation M Hashemi, F Ghadyani, S Hasani, Y Olyaee, B Raei, M Khodadadi, ... Journal of Drug Delivery Science and Technology 80, 104112, 2023 | 27 | 2023 |
| Cancer stem cells: The important role of CD markers, Signaling pathways, and MicroRNAs A Gholamzad, N Khakpour, EM Khosroshahi, S Asadi, ZK Koohpar, ... Pathology-Research and Practice, 155227, 2024 | 7 | 2024 |
| miRNAs and exosomal miRNAs in lung cancer: New emerging players in tumor progression and therapy response AT M Hashemi, EM Khosroshahi, MK Chegini, M Abedi, A Matinahmadi, Y Sotodeh ... Pathology - Research and Practice, 2023 | 6 | 2023 |
| Assessing Gene Expression and Methylation of KMT2D and IGF2 Genes in Patients with Non-Small Cell Lung Cancer A Matinahmadi, H Ghasemi, S Nooshin, Z Zayani, SZ Karizi, M Karimipoor Cancer and Clinical Oncology 7 (1), 55, 2018 | 3 | 2018 |
| The Methylation Analysis of KLF11 and PCDH9 Genes in Patients with Non-Small Cell Lung Cancer S Nooshin, SZ Karizi, M Karimipoor, M Nooshin, A Matinahmadi, ... Cancer and Clinical Oncology 7 (1), 47, 2018 | 3 | 2018 |
| Prostate Cancer, Apoptosis, Autophagy and Ferroptosis: Cell Death Mechanisms and Their Cross-talk M Hashemi, AS Hosseini, S Monjezi, S Hasany, S Binaei, M Nejat, ... Prostate Cancer: Molecular Events and Therapeutic Modalities, 71-107, 2024 | 1 | 2024 |
| Targeting autophagy can synergize the efficacy of immune checkpoint inhibitors against therapeutic resistance: New promising strategy to reinvigorate cancer therapy M Hashemi, EM Khosroshahi, M Tanha, S Khoushab, A Bizhanpour, ... Heliyon 10 (18), 2024 | | 2024 |
| Abstract B029: Assessing gene expression and methylation of KMT2D and IGF2 genes in patients with non-small cell lung cancer A Matinahmadi, Z Zayani, SH Bidooki, A Tavakolpournegari Molecular Cancer Therapeutics 23 (6_Supplement), B029-B029, 2024 | | 2024 |
| Abstract B030: Expression patterns of miR181a and miR30d in patients with breast cancer A Tavakolpournegari, M Hashemi, A Matinahmadi, SS Moosavi, ... Molecular Cancer Therapeutics 23 (6_Supplement), B030-B030, 2024 | | 2024 |
| Epigenetic regulation of hepatocellular carcinoma progression: microRNAs as therapeutic, diagnostic and prognostic factors MASG M Hashemi, P Daneii, M Asadalizadeh, K Tabari, A Matinahmadi, S ... The International Journal of Biochemistry & Cell Biology, 2024 | | 2024 |
| Evaluation of changes in interleukin 33 in Alzheimer's disease model and changes caused by propolis treatment on brain tissue of rats G Banaei, S Zarrabian, F Rouhollah, SH Bidooki, A Matinahmadi, ... | | 2023 |
| Post transcriptional regulations and Proteins implicated to transcripts degradation in the cytoplasm-research using a model Plant (Larix decidua) Arash Matinahmadi, Dariusz Jan Smolinski European Molecular Biology Organization (EMBO), 2022 | | 2022 |
| Expression Patterns of miR181a and miR30d in Patients with Breast Cancer A Tavakolpournegari, M Hashemi, SZ Karizi, AM Ahmadi, SH Bidooki, ... Iranian Journal of Public Health 51 (7), 1594, 2022 | | 2022 |
| The Methylation Analysis of Mir-210 in NSCLC Patients M Masrouri, S Nooshin, AM Ahmadi, RZ Zadeh, MM Pahmadani, ... | | 2018 |
| The Expression Analysis of KLF11, PCDH9 and TGF-Β2 Genes in Patients with Non-Small Cell Lung Cancer MA Anary, S Nooshin, AM Ahmadi, AT Negari | | 2018 |
| KMT2D and IGF2 Genes Expression in Breast Cancer Patients AT Negari, A Emamvirdizadeh, M Majdnia, AM Ahmadi, F Shahbazi, ... Age 7, 20, 2018 | | 2018 |
Mehrdad HashemiProfessor在 iautmu.ac.ir 的电子邮件经过验证
